医学
紫杉醇
过敏反应
过敏反应
药品
化疗
药理学
术前用药
不利影响
脱敏(药物)
临床试验
药物过敏
摘要
To evaluate clinical literature supporting the prophylactic use of single-dose intravenous dexamethasone to prevent hypersensitivity reactions (HSRs) to paclitaxel infusion.Clinical literature accessed through MEDLINE (from 1986 to 2000).Prophylaxis for paclitaxel-related HSRs generally includes repeated dexamethasone doses beginning 12 hours before paclitaxel, and administration of diphenhydramine plus a histamine2-receptor antagonist 30 minutes before infusion of paclitaxel. Singe-dose intravenous dexamethasone administered with ancillary medications 30 minutes before infusion of paclitaxel has been used to prevent regimen-related HSRs.Single-dose intravenous dexamethasone can be used in combination with appropriate ancillary medications to prevent paclitaxel-related HSRs.
科研通智能强力驱动
Strongly Powered by AbleSci AI